Charles River Laboratories and ENYO Pharma today announced results of a successful collaboration
(http://ir.criver.com/phoenix.zhtml?c=121668&p=irol-newsArticle&ID=2318801)
Read next in 'Latest news'
- Nouvelle publication : An anti-diabetic drug targets NEET (CISD) proteins through destabilization of their [2Fe-2S] clusters
- New publication : An anti-diabetic drug targets NEET (CISD) proteins through destabilization of their [2Fe-2S] clusters
- Swiss NASH Foundation sponsorship
- ENYO Pharma in the Top 50 of the EIC ScalingUp List
- Selection in the Best of the Liver Meeting 2021
Latest Press Release 